围术期红细胞输注对心脏手术患者的长期影响
该研究纳入2010至2018年接受开放心脏手术的14281例患者,中位随访4.03年,比较围术期输注与未输注浓缩红细胞(PRBC)患者的结局。输注PRBC与更高的手术死亡率、远期死亡率和再入院率独立相关,且输注总单位数与死亡率和再入院直接相关。
要点
- 围术期PRBC输注是心脏手术患者远期死亡率的独立预测因子(HR 2.39)。
- PRBC输注总单位数与死亡率和再入院风险呈直接关联。
- 输注PRBC患者术后并发症(肺炎、卒中、脓毒症、肾衰竭等)发生率显著更高。
核心结论
- 围术期PRBC输注与心脏手术患者更高的手术死亡率和远期死亡率及再入院率相关。
- PRBC输注总单位数与死亡率和再入院风险直接相关。
研究设计与样本
- 回顾性队列研究,纳入2010至2018年所有接受开放心脏手术的患者,排除移植、使用心室辅助装置和需要循环停跳者。
- 共纳入14281例患者,中位随访4.03年(范围2.25-6.1年),按是否使用PRBC分为输注组(n=6239)和未输注组(n=8042)。
临床怎么用
- 心脏手术围术期应审慎评估PRBC输注指征,优化血液管理以减少不必要的输血。
- 对接受PRBC输注的患者,应加强术后并发症监测和出院后随访,警惕再入院风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: There is a known association between need for transfusion and short-term outcomes in patients undergoing cardiac surgery. However long-term data are lacking in the contemporary literature. METHODS: All patients who underwent open cardiac surgery from 2010 to 2018 were included, except those undergoing transplant, with a ventricular-assist device, and requiring circulatory arrest. Primary outcome included short- and long-term mortality. Secondary outcomes included postoperative complications and hospital readmissions. RESULTS: The total patient population included 14,281 patients with a median follow-up of 4.03 years (range, 2.25-6.1). Outcomes were stratified into patients with (n = 6239) or without (n = 8042) packed red blood cell (PRBC) use. Patients with PRBC transfusions had significantly (P < .001) worse postoperative outcomes compared with those without PRBC use, including higher operative mortality (6.89% vs 0.98%), return to the operating room (17.8% vs 1.61%), pneumonia (7.84% vs 0.98%), stroke (3.22% vs 1.51%), sepsis (2.66% vs 0.20%), renal failure (8.42% vs 1.12%), and dialysis (5.74% vs 0.42%). On multivariate analysis PRBC transfusion was an independent predictor of mortality (hazard ratio [[HR], 2.39; 95% confidence interval [CI], 2.08-2.64; P < .001) and hospital readmission (HR, 1.15; 95% CI, 1.09-1.21; P < .001). Total units of PRBCs were directly associated with mortality (HR, 1.09; 95% CI, 1.08-1.09; P < .001) and hospital readmissions (HR, 1.02; 95% CI, 1.01-1.03; P < .005). CONCLUSIONS: Patients with perioperative PRBC transfusions have increased operative and long-term mortality and hospital readmissions. Total units of PRBCs transfused were directly associated with mortality and readmissions.
引用
- Sultan I, Bianco V, Brown JA, et al. Long-term Impact of Perioperative Red Blood Cell Transfusion on Patients Undergoing Cardiac Surgery. Ann Thorac Surg. 2020. PMID: 33171175. doi:10.1016/j.athoracsur.2020.10.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。